Famciclovir

Hubei Yitai Pharmaceutical, established in 1999, manufactures prophylactic biological products, chiral intermediates, excipients, and fine chemicals, distributing to markets across North America, Central/South America, Western Europe, Australasia, Asia, Africa, Eastern Europe, and the Middle East. The company competes on brand recognition, an experienced R&D staff, delivery reliability, a large product line, and accommodation of buyers' specifications.